| Attribute |
Value |
| 52 Week Change |
-0.7 |
| Address1 |
13 Gad Feinstein Street |
| Address2 |
Park Rehovot |
| All Time High |
203.9 |
| All Time Low |
0.35 |
| Ask |
0.44 |
| Ask Size |
6 |
| Average Analyst Rating |
1.0 - Strong Buy |
| Average Daily Volume10 Day |
7,287,330 |
| Average Daily Volume3 Month |
1,466,189 |
| Average Volume |
1,466,189 |
| Average Volume10Days |
7,287,330 |
| Beta |
0.716 |
| Bid |
0.42 |
| Bid Size |
1 |
| Book Value |
-0.243 |
| City |
Rehovot |
| Compensation As Of Epoch Date |
1,735,603,200 |
| Country |
Israel |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.3891 |
| Current Ratio |
3.566 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
0.3895 |
| Day Low |
0.3726 |
| Debt To Equity |
36.425 |
| Display Name |
Evogene |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,787,058,000 |
| Earnings Call Timestamp Start |
1,787,058,000 |
| Earnings Timestamp |
1,787,056,200 |
| Earnings Timestamp End |
1,795,091,400 |
| Earnings Timestamp Start |
1,795,091,400 |
| Ebitda |
-13,869,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.51 |
| Enterprise To Revenue |
4.27 |
| Enterprise Value |
7,074,603 |
| Eps Current Year |
-1.1 |
| Eps Forward |
-0.6 |
| Eps Trailing Twelve Months |
-1.55 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
972 8 946 6724 |
| Fifty Day Average |
0.5156 |
| Fifty Day Average Change |
-0.12650004 |
| Fifty Day Average Change Percent |
-0.2453453 |
| Fifty Two Week Change Percent |
-70.0 |
| Fifty Two Week High |
1.49 |
| Fifty Two Week High Change |
-1.1009 |
| Fifty Two Week High Change Percent |
-0.7388591 |
| Fifty Two Week Low |
0.35 |
| Fifty Two Week Low Change |
0.03909999 |
| Fifty Two Week Low Change Percent |
0.111714266 |
| Fifty Two Week Range |
0.35 - 1.49 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,287,149,400,000 |
| Float Shares |
12,383,672 |
| Forward Eps |
-0.6 |
| Forward P E |
-0.64849997 |
| Free Cashflow |
-1,977,500 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
38 |
| Fullday Change |
0.0025999844 |
| Fullday Change Percent |
0.6726997 |
| Fullday Price |
0.3891 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
-0.67592 |
| Gross Profits |
-1,120,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.24385999 |
| Held Percent Institutions |
0.055710003 |
| Implied Shares Outstanding |
15,801,407 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,721,865,600 |
| Last Split Factor |
1:10 |
| Long Business Summary |
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel. |
| Long Name |
Evogene Ltd. |
| Market |
us_market |
| Market Cap |
6,148,327 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_3274115 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-17,832,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
7,594,738 |
| Number Of Analyst Opinions |
1 |
| Open |
0.385 |
| Operating Cashflow |
-10,947,000 |
| Operating Margins |
-6.06628 |
| Payout Ratio |
0.0 |
| Phone |
972 8 931 1900 |
| Previous Close |
0.3865 |
| Price Eps Current Year |
-0.35372725 |
| Price Hint |
4 |
| Price To Book |
-1.6012346 |
| Price To Sales Trailing12 Months |
3.7105172 |
| Profit Margins |
0.0 |
| Quick Ratio |
3.229 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.0 |
| Region |
US |
| Regular Market Change |
0.0025999844 |
| Regular Market Change Percent |
0.6726997 |
| Regular Market Day High |
0.3895 |
| Regular Market Day Low |
0.3726 |
| Regular Market Day Range |
0.3726 - 0.3895 |
| Regular Market Open |
0.385 |
| Regular Market Previous Close |
0.3865 |
| Regular Market Price |
0.3891 |
| Regular Market Time |
1,791,912,431 |
| Regular Market Volume |
80,444 |
| Return On Assets |
-0.37527 |
| Return On Equity |
-1.82748 |
| Revenue Growth |
-0.607 |
| Revenue Per Share |
0.165 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
15,801,407 |
| Shares Percent Shares Out |
0.059 |
| Shares Short |
932,725 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
53,001 |
| Short Name |
Evogene Ltd. |
| Short Percent Of Float |
0.0594 |
| Short Ratio |
0.28 |
| Source Interval |
15 |
| Symbol |
EVGN |
| Target High Price |
2.15 |
| Target Low Price |
2.15 |
| Target Mean Price |
2.15 |
| Target Median Price |
2.15 |
| Total Cash |
9,316,000 |
| Total Cash Per Share |
0.688 |
| Total Debt |
2,101,000 |
| Total Revenue |
1,657,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.55 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
0.7125 |
| Two Hundred Day Average Change |
-0.3234 |
| Two Hundred Day Average Change Percent |
-0.45389473 |
| Type Disp |
Equity |
| Volume |
80,444 |
| Website |
https://www.evogene.com |
| Zip |
7,638,517 |